The Patent Finder
CI

Corium Innovations, Inc.

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Four patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2034. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2034
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2018 to 2035.
US 11,565,097 Microarray for Delivery of Therapeutic Agent and Methods of Use Mar 13, 2034
US 10,384,046 Microarray for Delivery of Therapeutic Agent and Methods of Use Oct 22, 2034
US 11,052,231 Microarray for Delivery of Therapeutic Agent and Methods of Use Dec 25, 2034
US 9,962,534 Microarray for Delivery of Therapeutic Agent, Methods of Use, and Methods of Making Mar 28, 2035
20222026203020342035
1 pending application: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 20, 2027
    The maintenance fee for Microarray for Delivery of Therapeutic Agent and Methods of Use (US 10,384,046) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 1 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

PatentTitleStatusExpiresConfidence
US 11,565,097Microarray for Delivery of Therapeutic Agent and Methods of Use
In force
 · Low confidence
In forceLow confidence
US 10,384,046Microarray for Delivery of Therapeutic Agent and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 11,052,231Microarray for Delivery of Therapeutic Agent and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 9,962,534Microarray for Delivery of Therapeutic Agent, Methods of Use, and Methods of Making
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 1 application pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited